| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2022 | UTMD Utah Medical Products Inc | Richins Paul O61 | Director | Sell | 449 | $90.81 | $40,773.69 | -2.0% | -0.1% | -9.0% | |
| Nov 18, 2022 | VERO Venus Concept Inc. | Varghese Hemanth Jacob | President/ Chief Bus. Officer | Buy | 250,000 | $0.20 | $50,000.00 | New | +42.4% | -30.5% | |
| Nov 18, 2022 | PODD Insulet Corp | Manea Dan62 | SVP, Chief Hr Officer | Sell | 200 | $294.62 | $58,924.00 | -6.0% | +1.1% | -41.1% | |
| Nov 18, 2022 | BSX Boston Scientific Corp | Thepaut Eric Francis Yves | EVP &Pres, Eur, Mid-east, Afr | Sell | 14,952 | $42.72 | $638,773.36 | -20.6% | +8.2% | +26.5% | |
| Nov 18, 2022 | PETV Petvivo Holdings, Inc. | Rudelius Robert James | Director | Buy | 1,640 | $2.56 | $4,202.00 | +0.4% | - | - | |
| Nov 18, 2022 | OM Outset Medical, Inc. | Brottem John L.84 | General Counsel | Sell | 1,918 | $19.00 | $36,442.00 | -5.8% | +28.7% | -72.9% | |
| Nov 18, 2022 | VERO Venus Concept Inc. | Hollmig Stanley Tyler | Director | Buy | 250,000 | $0.20 | $50,000.00 | +625.0% | +42.4% | -30.5% | |
| Nov 18, 2022 | VERO Venus Concept Inc. | De Silva Rajiv | Officer | Buy | 1,250,000 | $0.20 | $250,000.00 | New | +42.4% | -30.5% | |
| Nov 18, 2022 | DXR Daxor Corp | Michel Robert J61 | Chief Financial Officer | Buy | 1,000 | $10.00 | $10,000.00 | +16.0% | -12.5% | -24.0% | |
| Nov 18, 2022 | PETV Petvivo Holdings, Inc. | Lai John | CEO And President | Buy | 1,110 | $2.60 | $2,884.98 | - | - | - | |
| Nov 18, 2022 | PODD Insulet Corp | Christensen Bret | EVP And CCO | Sell | 3,000 | $295.15 | $885,450.00 | -15.3% | +1.1% | -41.1% | |
| Nov 18, 2022 | UFPT Ufp Technologies Inc | Bailly R Jeffrey55 | President And CEO | Sell | 51,085 | $116.27 | $5,939,564.99 | -6.7% | -3.0% | +39.8% | |
| Nov 18, 2022 | XAIR Beyond Air, Inc. | Carey Robert | Director | Buy | 50,000 | $5.88 | $294,000.00 | +2.2% | +4.5% | -74.2% | |
| Nov 18, 2022 | BLFS Biolife Solutions Inc | De Greef Roderick74 | COO &President | Sell | 3,000 | $22.67 | $68,010.00 | -1.6% | +7.3% | -39.8% | |
| Nov 18, 2022 | ECIA Encision Inc | Fries Robert H | Director | Buy | 25,000 | $0.44 | $11,121.38 | +2.2% | - | - | |
| Nov 17, 2022 | NVST Envista Holdings Corp | Yu Howard H71 | Chief Financial Officer | Sell | 657 | $36.55 | $24,013.35 | -1.3% | +11.1% | -35.3% | |
| Nov 17, 2022 | PETV Petvivo Holdings, Inc. | Lai John | CEO And President | Buy | 1,856 | $2.47 | $4,583.83 | - | - | - | |
| Nov 17, 2022 | TMCI Treace Medical Concepts, Inc. | Elder Scot Michael | *see "remarks" | Buy | 3,736 | $21.48 | $80,231.72 | +19.8% | +3.1% | -60.2% | |
| Nov 17, 2022 | RDGL Vivos Inc | Korenko Michael K | CEO And President | Buy | 200,000 | $0.05 | $10,340.00 | +2.1% | - | - | |
| Nov 17, 2022 | DXR Daxor Corp | Desrosiers Caleb | Director | Buy | 3,157 | $9.50 | $29,991.50 | New | -11.8% | -24.5% | |
| Nov 17, 2022 | TMCI Treace Medical Concepts, Inc. | Treace John T.60 | Chief Executive Offer | Buy | 10,000 | $21.67 | $216,714.00 | +0.2% | +3.1% | -60.2% | |
| Nov 17, 2022 | UTMD Utah Medical Products Inc | Richins Paul O61 | Director | Sell | 161 | $90.00 | $14,490.00 | -0.7% | +0.9% | -6.4% | |
| Nov 17, 2022 | ECOR Electrocore, Inc. | Errico Joseph P59 | Director | Buy | 100,000 | $0.31 | $31,240.00 | +4.8% | -19.2% | +24.0% | |
| Nov 17, 2022 | LNSR Lensar, Inc. | Winer Gary M53 | Director | Buy | 2,500 | $4.16 | $10,400.00 | +3.6% | -22.4% | -46.6% | |
| Nov 16, 2022 | EKSO Ekso Bionics Holdings, Inc. | Wong Jerome55 | Chief Financial Officer | Sell | 723 | $1.28 | $927.25 | -0.7% | +27.5% | +11.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.